EVERSANA Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life Sciences

EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, today unveiled EVERSANA INTOUCH, marking the transformation of its full-service, global healthcare agency network serving the life sciences industry. Combining the power of world-class creative, media and digital innovation with payer, patient, and healthcare communications expertise, EVERSANA INTOUCH reinvents life sciences marketing as the first and only agency accelerating brand performance through insights and seamless connectivity to EVERSANA’s integrated commercialization solutions.

Read more
/by

Leaderboard Branding Adds to Expert Drug Safety Division With Influential Hire: Former FDA DMEPA Evaluator

,

Leaderboard Branding, a Fingerpaint company – the fast-growing global naming and branding firm that delivers strategic insights and world-class creativity to biopharma and healthcare companies as early as clinical phase 1 – announced the hiring of Max Straka, PharmD, FISMP, a former FDA Division of Medication Error Prevention and Analysis (DMEPA) safety evaluator. As a Director of Leaderboard Branding’s Drug Safety Division, Dr. Straka adds to the broad experience of global leaders and innovators in this important area of drug development.

Read more
/by

Data-driven policy and market access firm Avalere joins Fishawack Health

, ,

Fishawack Health (FH) announces the acquisition of leading healthcare consulting and advisory firm Avalere Health from Inovalon, which acquired the consultancy in 2015.

Read more
/by

CMI Media Group Celebrates 10th Anniversary of Industry-First HCP and Consumer Engagement Platform

CMI Media Group, a leading media agency to healthcare’s game changers and a WPP company, on Monday celebrated the 10th anniversary of the industry-changing platform, Empower™. According to CMI Media Group, this is the industry’s first and only people-first precision and performance data platform that manages the complete marketing process. From insights to planning and media activation to optimization, Empower™ leverages consistent healthcare audience data.

Read more
/by

IPG Health Launches 90NORTH, a New Platform-Based Advisorship

IPG Health is proud to announce the launch of 90NORTH, the network’s new software-based advisorship that enables pharmaceutical, biotech and life science companies to tackle complex issues beyond traditional marketing communications. 90NORTH, its name derived from the coordinates for the north pole, uses proprietary software platforms that help clients solve complex business problems and uncover innovative areas for competitive advantage and growth.

Read more
/by

Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug

,

Amarin Corp. Plc said on Monday the company would cut its workforce by 40 percent, as the drugmaker’s fish-oil derived heart drug faces stiff competition from generic rivals in the United States.

Read more
/by
Reid Connolly, Evoke

Evoke and Ashfield Health join forces to form new agile global platform

Today, Evoke announces the integration of Ashfield Health marketing and communications agencies to form a new global healthcare brand, experience and communications platform, purpose-built to make health more human. The combination of two leading global healthcare organizations in one agile platform under the Evoke name creates one of the industry’s deepest and most dynamic marketing and communications offerings.

Read more
/by
Matt McNally

Omnicom Names Matt McNally CEO of Omnicom Health Group

,

Omnicom Group today announced the appointment of Matt McNally as CEO of Omnicom Health Group (OHG), the largest healthcare marketing and communications network in the world and part of Omnicom’s DAS Group of Companies (DAS). McNally succeeds Ed Wise, who held the chief executive role since OHG’s formation in 2016 and recently announced his retirement.

Read more
/by

Regeneron buys rights to cancer drug Libtayo from Sanofi

, ,

Regeneron Pharmaceuticals Inc. said on Thursday the company would buy the global rights to the cancer drug Libtayo from French drugmaker Sanofi SA in a deal that includes an upfront payment of $900 million.

Read more
/by

EVERSANA and Limitless Minds Advance Pharmaceutical Sales Performance with New Cognitive & Behavioral Training Solution

EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, and Limitless Minds, a business and wellness coaching firm founded by professional athlete Russell Wilson and co-founders Trevor Moawad, Harrison Wilson and DJ Eidson, announced the launch of an integrated learning and performance solution for life sciences professionals.

Read more
/by